ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2017. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $10,000 | +11.1% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $9,000 | +200.0% | 200 | 0.0% | 0.00% | +200.0% |
| Q1 2017 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | -75.0% |
| Q4 2015 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $5,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |